S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.21%)
T   16.80 (+1.27%)
F   12.14 (+0.17%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.44 (+0.45%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.21%)
T   16.80 (+1.27%)
F   12.14 (+0.17%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.44 (+0.45%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.21%)
T   16.80 (+1.27%)
F   12.14 (+0.17%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.44 (+0.45%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.21%)
T   16.80 (+1.27%)
F   12.14 (+0.17%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.44 (+0.45%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)

Theravance Biopharma (TBPH) SEC Filings & 10K Form

$8.98
+0.30 (+3.46%)
(As of 04:00 PM ET)

Recent Theravance Biopharma SEC Filings

DateFilerForm TypeView
02/16/2024
7:12 PM
Miller Aine (Reporting)
Theravance Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/16/2024
5:16 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
5:07 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
5:01 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2023
5:06 PM
Grant Jeremy T (Reporting)
Theravance Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/26/2023
5:09 PM
Grant Jeremy T (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2023
4:10 PM
Theravance Biopharma (Filer)
Form DEFA14A
12/21/2023
4:06 PM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2023
5:07 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
5:10 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
5:11 PM
Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
5:14 PM
Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
5:16 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
5:16 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2023
3:10 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/09/2023
3:46 PM
Theravance Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2023
3:53 PM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2023
5:35 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2023
4:15 PM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2023
5:54 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2023
3:13 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2023
5:08 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
3:24 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2023
5:05 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/24/2023
5:05 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2023
5:10 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2023
5:13 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2023
5:15 PM
Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2023
5:17 PM
Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2023
5:19 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
5:09 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2023
4:00 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2023
5:16 AM
Theravance Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/18/2023
5:14 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2023
1:59 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2023
3:33 PM
BAUPOST GROUP LLC/MA (Filed by)
Theravance Biopharma (Subject)
Form SC 13G/A
06/16/2023
5:14 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
7:02 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2023
5:08 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
4:11 PM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2023
4:11 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2023
6:41 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2023
6:44 PM
Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2023
6:46 PM
Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2023
6:48 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2023
6:40 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2023
5:17 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2023
5:16 AM
Theravance Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2023
5:33 PM
Smaldone Alsup Laurie (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
5:36 PM
BROSHY ERAN (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
5:38 PM
GRAY SUSANNAH (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
5:41 PM
MALKIEL BURTON G (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
5:43 PM
MITCHELL DEAN J (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
5:46 PM
O'Connor Donal (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
5:48 PM
PAKIANATHAN DEEPIKA (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2023
3:28 PM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2023
6:16 PM
Kelly James Connor (Reporting)
Theravance Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/18/2023
4:49 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2023
5:03 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2023
2:21 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/12/2023
12:51 PM
Theravance Biopharma (Subject)
Weiss Asset Management LP (Filed by)
Form SC 13D
04/11/2023
3:24 PM
Theravance Biopharma (Filer)
Form DEFA14A
04/11/2023
3:27 PM
Theravance Biopharma (Filer)
Form DEFA14A
03/16/2023
6:04 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2023
4:57 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2023
5:07 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2023
6:34 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2023
7:38 PM
Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2023
7:41 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2023
7:29 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2023
7:32 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2023
7:35 PM
Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2023
3:39 PM
Theravance Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2023
7:14 PM
GRAY SUSANNAH (Reporting)
Theravance Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/28/2023
7:17 PM
GRAY SUSANNAH (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2023
4:26 PM
Theravance Biopharma (Filer)
Form DEFA14A
02/28/2023
7:19 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2023
7:21 AM
Theravance Biopharma (Filer)
Form DEFA14A
02/22/2023
6:27 PM
Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
6:29 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
6:18 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
6:21 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
6:23 PM
Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
4:05 PM
Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:TBPH) was last updated on 2/23/2024 by MarketBeat.com Staff